For 30 years Drugs & Aging has been delivering essential information on the most important aspects of drug therapy to researchers and healthcare professionals involved in the care of older patients.

Through a program of reviews and original research articles, the journal addresses major issues relating to drug therapy in older adults, including the management of specific diseases or disorders, particularly those associated with aging, age-related physiological changes impacting drug therapy, and issues related to drug utilization and prescribing.

As a hybrid journal, Drugs & Aging does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.

Drugs & Aging offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Journal information

Editor
  • Caroline Herdson
Publishing model
Hybrid. How to publish with us, including Open Access

Journal metrics

4.271 (2021)
Impact factor
4.094 (2021)
Five year impact factor
20 days
Submission to first decision (Median)
267,100 (2021)
Downloads

Latest articles

Journal updates

  • Digital Features

    Drugs & Aging is able to host a range of digital features, with a number of options available to authors.

    Digital Features
View all updates

Working on a manuscript?

Avoid the most common mistakes and prepare your manuscript for journal editors.

Learn more

About this journal

Electronic ISSN
1179-1969
Print ISSN
1170-229X
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. CAB Abstracts
  6. CLOCKSS
  7. CNKI
  8. CNPIEC
  9. Chemical Abstracts Service (CAS)
  10. Current Contents/ Life Sciences
  11. Current Contents/Clinical Medicine
  12. Dimensions
  13. EBSCO Abstracts in Social Gerontology
  14. EBSCO Academic Search
  15. EBSCO Advanced Placement Source
  16. EBSCO Biomedical Reference Collection
  17. EBSCO CINAHL
  18. EBSCO Discovery Service
  19. EBSCO MasterFILE
  20. EMBASE
  21. EMCare
  22. Google Scholar
  23. Japanese Science and Technology Agency (JST)
  24. Journal Citation Reports/Science Edition
  25. Medline
  26. Naver
  27. OCLC WorldCat Discovery Service
  28. Pathway Studio
  29. Portico
  30. ProQuest-ExLibris Primo
  31. ProQuest-ExLibris Summon
  32. Reaxys
  33. SCImago
  34. SCOPUS
  35. Science Citation Index Expanded (SCIE)
  36. Semantic Scholar
  37. TD Net Discovery Service
  38. UGC-CARE List (India)
  39. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG